Vidya Sabale
Overview
Explore the profile of Vidya Sabale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunte R, Sabale P, Waghmare S, Jiwankar M, Sabale V
Pharm Nanotechnol
. 2025 Mar;
PMID: 40070335
Cancer is a leading cause of death and life-threatening disease globally. It is connected to persistent tissue damage and unregulated cellular proliferation. In females, breast cancer plays a crucial role...
2.
Sabale V, Girhepunje M, Ingole A, Warokar A, Sawarkar K, Sabale P
Int J Biol Macromol
. 2025 Feb;
306(Pt 1):141257.
PMID: 39986527
This study developed a mucoadhesive self-nano emulsifying drug delivery system (SNEDDS) with synthesized acyl chitosan coating for enhancing oral bioavailability and drug retention of Amphotericin B (AB) which is conventionally...
3.
Sabale V, Ingole A, Pathak R, Sabale P
AAPS PharmSciTech
. 2025 Feb;
26(2):62.
PMID: 39934622
Capecitabine, an oral prodrug of 5-fluorouracil, is increasingly being loaded into various drug delivery system to enhance its bioavailability and cytotoxicity. This study aimed to prepare and evaluate capecitabine-loaded niosomes...
4.
Sabale P, Sayyad N, Ali A, Sabale V, Kaleem M, Asar T, et al.
RSC Adv
. 2024 Jul;
14(33):23785-23795.
PMID: 39077323
In both premenopausal and postmenopausal women, oestrogens play a critical role in the development of breast cancer. Aromatase is an enzyme that catalyses the final step in the biosynthesis of...
5.
Mujtaba M, Kaleem M, Chaware R, Ingole A, Asiri Y, Hassan M, et al.
ACS Omega
. 2024 Apr;
9(14):16346-16357.
PMID: 38617636
This research work aimed to develop and evaluate proniosomes for the oral delivery of the lipophilic drug Irbesartan (IRB) to improve its solubility and bioavailability. Proniosomes of Irbesartan were formulated...
6.
Waghmare S, Palekar R, Potey L, Khedekar P, Sabale P, Sabale V
Pharm Nanotechnol
. 2024 Feb;
13(1):22-40.
PMID: 38317470
In order to overcome some of the drawbacks of traditional formulations, increasing emphasis has recently been paid to lipid-based drug delivery systems. Solid lipid nanoparticles (SLNs) are promising delivery methods,...
7.
Sabale V, Belokar V, Jiwankar M, Sabale P
Pharm Nanotechnol
. 2024 Jan;
13(1):171-183.
PMID: 38213174
Background: Nanostructured lipid carriers (NLCs) are explored as vehicles for ophthalmic drug delivery owing to their better drug loading, good permeation, and satisfactory safety profile. Objectives: The purpose of the...
8.
Sabale V, Charde M, Dumore N, Mahajan U
Curr Drug Deliv
. 2022 Apr;
20(6):683-693.
PMID: 35466874
Proniosomes are the stable carriers used for transdermal application as compared to other vesicular delivery systems like niosomes and liposomes. Oral administration of a drug is associated with severe GIT...
9.
Sabale V, Paranjape A, Patel V, Sabale P
Int J Biol Macromol
. 2016 Nov;
95:321-330.
PMID: 27889336
Identification and physiochemical parameters such as solubility, loss on drying, viscosity, pH, swelling index, starch and gum constituents were determined in natural polymers and showed satisfactory results. Spectral studies established...
10.
Sabale V, Vora S
Int J Pharm Investig
. 2013 Feb;
2(3):140-9.
PMID: 23373005
Background: The purpose of this study was to develop microemulsion-based hydrogel formulation for topical delivery of bifonazole with an objective to increase the solubility and skin permeability of the drug....